Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$4.76 USD
-0.02 (-0.42%)
Updated May 10, 2024 04:00 PM ET
After-Market: $5.12 +0.36 (7.56%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -2.82 |
EPS Last Quarter | -2.02 |
Last EPS Surprise | 43.73% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -10.93 |
Next Year | -8.35 |
EPS (TTM) | -13.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.82 | -2.41 | -10.93 | -8.35 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -3.59 | -2.82 | -10.80 | -8.35 |
High Estimate | -2.82 | -2.41 | -10.80 | -8.35 |
Low Estimate | -2.82 | -2.41 | -11.05 | -8.35 |
Year ago EPS | -3.00 | -2.85 | -225.94 | -10.93 |
Year over Year Growth Est. | 6.00% | 15.44% | 95.16% | 23.56% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.82 | -2.41 | -10.93 | -8.35 |
7 Days Ago | -2.82 | -2.41 | -10.93 | -8.35 |
30 Days Ago | -2.82 | -2.41 | -10.93 | -8.35 |
60 Days Ago | -2.40 | -2.55 | -10.27 | -9.45 |
90 Days Ago | -2.40 | -2.55 | -10.27 | -9.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.82 | -2.41 | -10.93 | -8.35 |
Zacks Consensus Estimate | -2.82 | -2.41 | -10.93 | -8.35 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.02 | NA | -2.85 | -3.00 | NA |
Estimate | -3.59 | NA | -3.15 | -4.20 | NA |
Difference | 1.57 | NA | 0.30 | 1.20 | 1.02 |
Surprise | 43.73% | NA | 9.52% | 28.57% | 27.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more